Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655

@article{Szabados2001ComparisonOA,
  title={Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655},
  author={T. Szabados and G. Gigler and I. Gacs{\'a}lyi and I. Gyertyán and G. L{\'e}vay},
  journal={Brain Research Bulletin},
  year={2001},
  volume={55},
  pages={387-391}
}
GYKI 52466 [1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine], a non-competitive AMPA [alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate] and kainate receptor antagonist and its two analogues, GYKI 53405 [1-(4-aminophenyl)-3-acetyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine] and GYKI 53655 [1-(4-aminophenyl)-3-methylcarbamyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine] were investigated in two seizure models and in MgCl2 induced global… Expand
42 Citations
Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives.
  • 35
New 7,8-ethylenedioxy-2,3-benzodiazepines as noncompetitive AMPA receptor antagonists.
  • 21
The effects of AMPA receptor antagonists in models of stroke and neurodegeneration.
  • 37
Comparison of the AMPA Antagonist Action of New 2,3-Benzodiazepines in Vitro and Their Neuroprotective Effects in Vivo
  • 14
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.
  • 66
Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
  • 93
  • PDF
...
1
2
3
...